By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Onconova Therapeutics Inc. 

P.O. Box 7693

Princeton  New Jersey  08543  U.S.A.
Phone: 609-844-7735 Fax:


SEARCH JOBS








Company News
Onconova Therapeutics Inc. (ONTX) To Present Corporate Update At The Cantor Fitzgerald Healthcare Conference 7/2/2015 7:45:58 AM
Onconova Therapeutics Inc. (ONTX) To Host Myelodysplastic Syndromes (MDS) Key Opinion Leader Meeting On Tuesday, June 30 In New York City 6/23/2015 10:56:51 AM
Onconova Therapeutics Inc. (ONTX) Presents Patient Selection Criteria And Intermediate Clinical Endpoints For Rigosertib In Higher-Risk Myelodysplastic Syndromes (HR-MDS) At European Hematology Association Annual Meeting 6/15/2015 9:06:56 AM
ASCO15: Onconova Therapeutics Inc. (ONTX) Presents Clinical Data On Rigosertib In Higher-Risk Myelodysplastic Syndromes (HR-MDS) At The 2015 ASCO Annual Meeting 6/1/2015 8:33:34 AM
Onconova Therapeutics Inc. (ONTX) Reports Recent Business Highlights And First Quarter 2015 Financial Results 5/15/2015 8:32:54 AM
Onconova Therapeutics Inc. (ONTX) Announces Multiple Rigosertib Clinical Data Presentations At The 2015 ASCO Annual Meeting 5/14/2015 1:00:43 PM
Onconova Therapeutics Inc. (ONTX) Presenting Nine Abstracts Related To Rigosertib At The 13th International Symposium On Myelodysplastic Syndromes (MDS) 5/1/2015 10:23:49 AM
Onconova Therapeutics Inc. (ONTX) Highlights Rigosertib And Early-Stage Programs At The 2015 AACR Annual Meeting 4/21/2015 4:45:39 PM
Onconova Therapeutics Inc. (ONTX) Submits Pivotal Clinical Trial Protocol For IV Rigosertib In Higher-Risk Myelodysplastic Syndromes To FDA And European Medicines Agency 4/20/2015 8:04:34 AM
Onconova Therapeutics Inc. (ONTX) To Present New Data On Rigosertib And Earlier-Stage Programs At The 2015 American Association for Cancer Research Annual Meeting 4/7/2015 7:27:56 AM
12345678
//-->